Honey guide
Why Raw Honey Fights Bacteria (What Science Actually Shows)
Raw honey's antibacterial mechanisms — hydrogen peroxide, low water activity, acidity, and methylglyoxal in Manuka — explained with UK clinical evidence and FSA rules.
By Honey Honey Honey · Published 3 June 2026
What are the proven antibacterial mechanisms in raw honey?
Raw honey kills or inhibits bacteria through four distinct mechanisms, all of which have been studied and confirmed in laboratory settings. No single mechanism is responsible — they work in combination, which is why honey's antibacterial activity is difficult for bacteria to evolve resistance against.
The first mechanism is hydrogen peroxide production. Glucose oxidase, an enzyme bees add to nectar during honey processing, converts glucose and oxygen into gluconic acid and hydrogen peroxide. This reaction continues slowly in stored honey, producing a steady low-level supply of hydrogen peroxide that disrupts bacterial cell function.
The second mechanism is low water activity. Honey has a water activity of around 0.6, far below the minimum of 0.91 that most bacteria need to function. Bacteria in honey are unable to access the water they need for metabolic processes and die or remain dormant.
The third mechanism is acidity. Honey's pH of 3.5 to 4.5 is hostile to the majority of pathogenic bacteria, which require a near-neutral pH to grow. This acidity is produced partly by gluconic acid from the same enzymatic reaction that generates hydrogen peroxide.
The fourth mechanism is osmotic pressure. The high sugar concentration creates a strong osmotic gradient that draws water out of bacterial cells through osmosis, causing them to dehydrate and die.
In Manuka honey, a fifth mechanism applies: methylglyoxal (MGO), which provides antibacterial activity that persists even when hydrogen peroxide is neutralised. This is what distinguishes Manuka from most other honeys in clinical applications.
These mechanisms collectively mean that raw honey is broadly antimicrobial without the narrow-spectrum targeting of pharmaceutical antibiotics, and without the corresponding risk of promoting resistance through a single inhibitory pathway.
How does glucose oxidase produce hydrogen peroxide in honey?
Glucose oxidase is an enzyme secreted by bees from their hypopharyngeal glands — a pair of glands in the head. Bees add it to nectar during the collection and processing phase, before honey is fully cured and capped in the comb.
The enzyme catalyses a specific reaction: glucose plus water plus oxygen produces gluconic acid and hydrogen peroxide. Both products are important. Gluconic acid accounts for most of honey's acidity. Hydrogen peroxide is the antimicrobial agent.
The reaction is self-regulating. Honey also contains catalase, which breaks hydrogen peroxide down into water and oxygen. This prevents peroxide from accumulating to levels that would damage honey's own chemical structure. The result is a steady-state concentration of peroxide — low but persistent.
In undiluted honey, hydrogen peroxide activity is relatively modest because catalase keeps it in check. But when honey is diluted — as happens when it is applied to a wound that is producing exudate, for example — the catalase becomes less concentrated and hydrogen peroxide activity increases. This is one reason why honey is particularly effective in moist wound environments: dilution activates the peroxide system.
Heating is the main threat to this mechanism. Glucose oxidase begins to denature at temperatures above around 40°C. Commercial processing often involves heating to 60°C or above for pasteurisation or to liquefy crystallised honey. This reduces or eliminates glucose oxidase activity. Ultra-heat-treated honey has no meaningful hydrogen peroxide production.
Raw honey from UK beekeepers who extract at ambient temperature and pack without heating retains active glucose oxidase. This is one of the key biochemical differences between raw and processed honey, and one of the reasons laboratory studies on honey's antibacterial activity typically use raw or minimally processed samples.
What bacteria has honey been tested against in laboratory studies?
Honey has been tested against a substantial range of bacterial species in laboratory conditions, and the results are consistently positive. The strongest and most replicated evidence covers both gram-positive and gram-negative bacteria.
Staphylococcus aureus, including methicillin-resistant strains (MRSA), is the most studied pathogen. Multiple studies have shown that Manuka honey and other high-activity honeys inhibit S. aureus in vitro at concentrations achievable in wound dressings. The minimum inhibitory concentrations are in the range of 5-10% honey, which is well within what medical honey products deliver.
Pseudomonas aeruginosa, a major problem in chronic wound infections and hospital-acquired infections, has also been tested. It is gram-negative and generally more resistant to many antibacterial agents, but is inhibited by high-activity honeys in laboratory settings. Pseudomonas forms biofilms — structures that protect bacteria from antibiotics — and there is some evidence that honey disrupts biofilm formation.
Escherichia coli, Streptococcus pyogenes, Helicobacter pylori, and various Salmonella species have all been tested with positive results in vitro. The caveat always applies: in vitro results do not automatically translate to clinical outcomes in people, because the biological environment in a wound or gut is far more complex than a petri dish.
Honey's antibacterial activity in laboratory testing is graded using minimum inhibitory concentration assays. Results vary significantly between honey types and even between batches of the same type, because glucose oxidase activity, water content, pH, and polyphenol content all vary. This is why medical honey products are standardised — raw honey from different sources is too variable for consistent clinical use.
Does processing destroy honey's antibacterial properties?
Processing reduces antibacterial activity significantly, primarily through the degradation of glucose oxidase. The hydrogen peroxide mechanism — the main antibacterial property of most honeys — depends on active enzyme. Heat processing above 40°C progressively destroys the enzyme, and the higher the temperature and longer the exposure, the greater the loss.
Commercial honey in UK supermarkets is typically pasteurised at 63°C or heated to similar temperatures to delay crystallisation and improve shelf presentation. This process effectively eliminates glucose oxidase activity. Heavily filtered honey also removes pollen, which carries some polyphenols with antioxidant and potentially antimicrobial properties.
The physical antibacterial properties — low water activity, high osmotic pressure, and acidity — are not destroyed by processing because they are functions of the sugar concentration and pH, not of enzymes. A processed honey still has these properties. However, the loss of hydrogen peroxide production removes one of the main active mechanisms.
Pasteurised honey can still be considered broadly antimicrobial in the sense that it will not allow microbial growth on its surface. But it is less active as an antibacterial agent on wounds or in laboratory assays compared to raw honey.
For wound care specifically, clinical products use raw Manuka honey as the base because methylglyoxal is not heat-sensitive in the same way glucose oxidase is. Methylglyoxal is a stable chemical compound, not an enzyme, so it survives processing. This is one reason Manuka is preferred for medical applications over generic raw honey — its primary antibacterial compound is stable.
The bottom line for UK consumers: if antibacterial activity matters to you — for a sore throat, minor wound, or general health use — raw honey is measurably more active than processed supermarket honey.
What is the difference between raw honey antibacterial activity and Manuka honey's?
Most raw honeys produce hydrogen peroxide as their primary antibacterial mechanism. Manuka honey has this mechanism too, but also has a second independent mechanism that makes it unique: high concentrations of methylglyoxal (MGO).
Methylglyoxal forms in Manuka honey through the conversion of dihydroxyacetone (DHA), a compound found in unusually high concentrations in the nectar of Leptospermum scoparium, the New Zealand Manuka shrub. MGO concentrations in genuine Manuka honey range from around 100mg/kg in low-rated products to over 800mg/kg in high-rated ones.
The significance of MGO is that it provides "non-peroxide activity" — antibacterial action that persists even when hydrogen peroxide is blocked or neutralised. Researchers first identified this in the 1990s by adding catalase (which destroys hydrogen peroxide) to honey samples and observing that Manuka retained strong antibacterial activity while other honeys lost most of theirs.
British raw honeys — wildflower, heather, clover, buckwheat — are not without antibacterial activity. Their hydrogen peroxide systems are intact, and darker varieties like heather and buckwheat have higher polyphenol content. But they do not contain meaningful MGO. The antibacterial activity of British raw honey is real but lower than high-grade Manuka in standardised assays.
The practical difference matters in a clinical context more than a dietary one. For wound treatment requiring sustained antibacterial activity in a moist environment, Manuka's MGO gives it an advantage. For general dietary use or minor throat applications, the difference is much less significant, and British raw honey at a fraction of the price performs a similar role.
What does UK clinical evidence say about honey as a wound treatment?
The clinical evidence for honey as a wound treatment in the UK is reasonably strong for specific wound types, particularly burns, leg ulcers, and certain surgical wounds. The evidence base is strongest for Manuka-based medical honey products, which are licensed for clinical use and available on NHS prescription.
The Cochrane Collaboration reviewed honey for wound care and found that honey heals partial-thickness burns more quickly than conventional dressings in several trials. For leg ulcers and other chronic wounds, the evidence is mixed — some trials show benefit, others show no significant difference against comparators. The overall conclusion is that honey is a legitimate treatment option, not a fringe remedy, but results depend heavily on wound type and which honey product is used.
UK hospitals use standardised, gamma-irradiated medical honey products such as Medihoney and L-Mesitran. These are not the same as shop-bought raw honey. They are sterilised to eliminate Clostridium botulinum spores and other potential contaminants, standardised for MGO content, and formulated into dressings with appropriate viscosity and adhesion. The NHS supplies these through its wound care formularies in trusts that include them.
For over-the-counter use — putting supermarket honey on a cut at home — the evidence is sparse and the product is not sterile. Minor scrapes cleaned and covered with raw honey will not come to harm, but it is not the same intervention as clinical honey dressings.
The NHS does not currently recommend shop-bought honey for wound management. The distinction between medical-grade and food-grade honey is important, and the clinical evidence applies specifically to the former.
Can raw honey kill antibiotic-resistant bacteria like MRSA?
Laboratory studies confirm that Manuka honey and some other high-activity honeys inhibit MRSA in vitro. The evidence is genuine and replicated across multiple research groups. However, the gap between "inhibits bacteria in a petri dish" and "treats MRSA infection in a patient" is large.
MRSA in a laboratory petri dish is exposed to honey directly, at controlled concentrations, in a controlled environment. MRSA in a person is embedded in tissue, often forming biofilms, potentially in deep wound beds where honey concentrations are hard to sustain. The clinical evidence for honey specifically treating MRSA infections is very limited, with only small case series and observational reports rather than controlled trials.
The more meaningful claim is that honey-based wound dressings reduce bacterial load in wounds colonised with MRSA, which is a more modest and better-supported position. A 2011 study in Cardiff used Manuka honey dressings on chronic wounds and found reduced MRSA colonisation compared to standard care.
The interest in honey as an anti-MRSA agent is partly driven by a genuine problem: MRSA is resistant to most standard antibiotics, and new antibiotic development is slow. Honey's multi-mechanism action means bacteria cannot easily develop resistance through a single mutation, which is different from the mechanism behind antibiotic resistance.
However, honey is not a replacement for antibiotic treatment of serious infections. NHS guidance and clinical microbiologists are clear that MRSA infections require appropriate antibiotic therapy where available, and honey dressings are an adjunct, not a primary treatment.
Why do some honey varieties have stronger antibacterial activity than others?
Antibacterial strength varies because it depends on several factors that differ between floral sources, beekeeping practices, and processing methods.
Glucose oxidase content varies between honey types. The enzyme comes from bees, but the amount in finished honey depends on how long the nectar was processed before capping, the bee colony's genetics and health, and whether the honey has been heated. Honeys from large-colony beekeeping operations where honey is quickly extracted may have different enzyme profiles from honey from small-scale apiaries.
Polyphenol content correlates with colour and is significantly higher in dark honeys. Buckwheat honey, the darkest common variety in British beekeeping, has among the highest polyphenol concentrations. Heather honey is also dark and polyphenol-rich. Polyphenols contribute to antibacterial activity independently of hydrogen peroxide. Light-coloured honeys like acacia are low in polyphenols and relatively mild in antibacterial activity.
Water content affects the osmotic mechanisms. Lower moisture means higher sugar concentration, which increases osmotic pressure. Well-ripened honey extracted from fully capped frames has lower moisture than honey harvested too early.
pH also varies between varieties. More acidic honeys (lower pH) are more hostile to bacteria. The acidity correlates with gluconic acid content, which correlates with glucose oxidase activity.
Finally, there is nectar-source chemistry. Some plants contribute phytochemicals directly to honey that have independent antimicrobial activity. Thyme honey, for example, contains thymol from the plant. Heather honey contains phenolics from heather. These compounds add to antibacterial activity beyond the enzymatic and physical mechanisms.
What health claims can honey sellers legally make under FSA rules in the UK?
UK honey sellers are bound by the Assimilated EU Regulation No 1924/2006 on Nutrition and Health Claims, enforced by the Food Standards Agency. The regulation is specific: any health claim made on food packaging or in marketing must either be an approved nutrition claim or an approved health claim from the permitted list.
No health claim linking honey directly to treating or preventing disease is permitted. Saying "honey treats infections" or "honey fights bacteria" on a label or in marketing materials would be an unlawful disease claim. The FSA can take enforcement action against sellers making such claims, and Trading Standards can prosecute under consumer protection law.
Approved nutrition claims are limited. You can state that honey "contains natural sugars" or make factual compositional statements. Some honeys have nutritional profiles that allow energy claims. Beyond that, the permitted claims list is restrictive.
The practical implication for UK honey sellers is that all the genuine science about antibacterial properties cannot be used in marketing without legal risk. This creates a gap between what researchers know and what sellers can say. Reputable UK honey businesses navigate this by publishing educational content, citing studies informatively rather than making direct product claims, and avoiding language that implies therapeutic benefit.
Manuka honey importers from New Zealand face the same restrictions. The UMF and MGO rating systems are product classification tools, not regulated health claims under FSA rules. Sellers can state the rating on the label but cannot legally claim that a higher rating means the product will treat a specific condition.
Consumers seeking information about honey's health properties need to look at peer-reviewed literature or authoritative sources like the NHS website, rather than product labels — because what product labels are permitted to say is intentionally limited.
Frequently asked questions
- Does raw honey kill bacteria?
- Yes. Raw honey has multiple antibacterial mechanisms including hydrogen peroxide production, low water activity, acidity, and high osmotic pressure. Laboratory studies confirm it inhibits a wide range of bacterial species.
- Is raw honey antibacterial without Manuka?
- Yes. Most raw honeys produce hydrogen peroxide and have low water activity and acidity. These are effective antibacterial mechanisms independent of the methylglyoxal found in Manuka.
- Does processing destroy honey's antibacterial properties?
- Heating honey above around 40°C degrades glucose oxidase, which eliminates the hydrogen peroxide mechanism. Ultra-processed honey has reduced antibacterial activity compared to raw honey.
- Can honey treat infected wounds?
- Medical-grade honey (gamma-irradiated) is licensed for clinical wound care in the UK. Shop-bought honey is not sterile and should not be used on wounds without medical advice.
- Can honey kill MRSA?
- Lab studies show that Manuka honey and some other honeys inhibit MRSA in vitro. Clinical evidence for treating MRSA infections in people is much more limited.
- What health claims can honey sellers make in the UK?
- UK sellers must comply with FSA rules and the EU-retained Nutrition and Health Claims Regulation. General disease treatment claims are prohibited. Only approved nutrition claims are permitted.
- Is honey an antibiotic?
- Honey has antibacterial properties but is not classified as an antibiotic. It works through different mechanisms than pharmaceutical antibiotics and cannot replace them for serious infections.
- Which raw honey has the strongest antibacterial activity?
- Antibacterial activity varies by floral source. Manuka has the strongest evidence due to methylglyoxal. Among British honeys, heather and buckwheat tend to show higher activity than light honeys like acacia.